RAVINDERJIT SINGH: Open Payments
NPI 1265695563 · DIAMOND SPRINGS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 11 payments from 6 companies in 2025. Trend: 2023 $373 · 2024 $595 · 2025 $749
Food & beverage: $638Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $233 |
| Neurocrine BioSciences, Inc. | 2 | $155 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 4 | $107 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
Products named: INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, COBENFY, Auvelity, CAPLYTA.
Industry payments across CA — which companies pay providers there.
